HSPA1A and neoplasm: As shown in Fig. 6E, administration of S1g-2 led to significant disruption of Hsp70-Bim PPI accompanied by significantly downregulated ERα36 expression in tumor samples, confirming that S1g-2 inhibited Hsp70-Bim in vivo as demonstrated previously in vitro experiments.